Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor

Journal of Medicinal Chemistry

Volumn 56, Issue 7, 2013, Pages 2936-2947

  Incerti, Matteo ^a   Tognolini, Massimiliano ^a   Russo, Simonetta ^a   Pala, Daniele ^a   Giorgio, Carmine ^a   Hassan Mohamed, Iftiin ^a   Noberini, Roberta ^b   Pasquale, Elena B ^b   Vicini, Paola ^a   Piersanti, Silvia ^a   Rivara, Silvia ^a   Barocelli, Elisabetta ^a   Mor, Marco ^a   Lodola, Alessio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ANGIOGENESIS INHIBITOR; CARBOXYL GROUP; EPHRIN RECEPTOR A2; LITHOCHOLIC ACID;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CONJUGATION; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

ADENOCARCINOMA; AMINO ACIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LITHOCHOLIC ACID; MALE; MODELS, MOLECULAR; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RECEPTOR, EPHA2;

EID: 84876273467     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301890k     Document Type: Article

References (51)

1. Gale, N. W.; Yancopoulos, G. D. Ephrins and their receptors: a repulsive topic? Cell Tissue Res. 1997, 290, 227-241
2. Himanen, J. P.; Saha, N.; Nikolov, D. B. Cell-cell signaling via Eph receptors and ephrins Curr. Opin. Cell. Biol. 2007, 19, 534-542
3. Pasquale, E. B. Eph receptor signalling casts a wide net on cell behaviour Nature Rev. Mol. Cell. Biol. 2005, 6, 462-475
4. Prevost, N.; Woulfe, D.; Tognolini, M.; Brass, L. F. Contact-dependent signaling during the late events of platelet activation J. Thromb. Haemostasis 2003, 1, 1613-1627
5. Pasquale, E. B. Eph-ephrin bidirectional signaling in physiology and disease Cell 2008, 133, 38-52
6. Pasquale, E. B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond Nature Rev. Cancer 2010, 10, 165-180
7. Brantley-Sieders, D. M. Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling Semin. Cell. Dev. Biol. 2012, 23, 102-108
8. Beauchamp, A.; Debinski, W. Ephs and ephrins in cancer: ephrin-A1 signalling Semin. Cell. Dev. Biol. 2012, 23, 109-115
9. Merlos-Suarez, A.; Batlle, E. Eph-ephrin signalling in adult tissues and cancer Curr. Opin. Cell. Biol. 2008, 20, 194-200
10. Noren, N. K.; Pasquale, E. B. Paradoxes of the EphB4 receptor in cancer Cancer Res. 2007, 67, 3994-3997
11. Kuijper, S.; Turner, C. J.; Adams, R. H. Regulation of angiogenesis by Eph-ephrin interactions Trends Cardiovasc. Med. 2007, 17, 145-151
12. Martiny-Baron, G.; Holzer, P.; Billy, E.; Schnell, C.; Brueggen, J.; Ferretti, M.; Schmiedeberg, N.; Wood, J. M.; Furet, P.; Imbach, P. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis Angiogenesis 2010, 13, 259-267
13. Wang, S.; Placzek, W. J.; Stebbins, J. L.; Mitra, S.; Noberini, R.; Koolpe, M.; Zhang, Z.; Dahl, R.; Pasquale, E. B.; Pellecchia, M. Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells J. Med. Chem. 2012, 55, 2427-2436
14. Tandon, M.; Vemula, S. V.; Mittal, S. K. Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opin. Ther. Targets 2011, 15, 31-51
15. Lafleur, K.; Huang, D.; Zhou, T.; Caflisch, A.; Nevado, C. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4) J. Med. Chem. 2009, 52, 6433-6446
16. Mamat, C.; Mosch, B.; Neuber, C.; Kockerling, M.; Bergmann, R.; Pietzsch, J. Fluorine-18 Radiolabeling and Radiopharmacological Characterization of a Benzodioxolylpyrimidine-Based Radiotracer Targeting the Receptor Tyrosine Kinase EphB4 ChemMedChem 2012, 7, 1991-2003
17. van Linden, O. P.; Farenc, C.; Zoutman, W. H.; Hameetman, L.; Wijtmans, M.; Leurs, R.; Tensen, C. P.; Siegal, G.; de Esch, I. J. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase Eur. J. Med. Chem. 2012, 47, 493-500
18. Noberini, R.; Lamberto, I.; Pasquale, E. B. Targeting Eph receptors with peptides and small molecules: progress and challenges Semin. Cell. Dev. Biol. 2012, 23, 51-7
19. Wells, J. A.; McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 2007, 450, 1001-1009
20. Jehle, J.; Staudacher, I.; Wiedmann, F.; Schweizer, P. A.; Becker, R.; Katus, H. A.; Thomas, D. Regulation of HL-1 cardiomyocyte apoptosis by EphA2 receptor tyrosine kinase phosphorylation and protection by lithocholic acid Br. J. Pharmacol. 2012, 167, 1563-1572
21. Giorgio, C.; Hassan Mohamed, I.; Flammini, L.; Barocelli, E.; Incerti, M.; Lodola, A.; Tognolini, M. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation PLoS One 2011, 6, e18128
22. Tognolini, M.; Incerti, M.; Hassan-Mohamed, I.; Giorgio, C.; Russo, S.; Bruni, R.; Lelli, B.; Bracci, L.; Noberini, R.; Pasquale, E. B.; Barocelli, E.; Vicini, P.; Mor, M.; Lodola, A. Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor ChemMedChem 2012, 7, 1071-1083
23. Noberini, R.; De, S. K.; Zhang, Z.; Wu, B.; Raveendra-Panickar, D.; Chen, V.; Vazquez, J.; Qin, H.; Song, J.; Cosford, N. D.; Pellecchia, M.; Pasquale, E. B. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors Chem. Biol. Drug Des. 2011, 78, 667-678
24. Noberini, R.; Koolpe, M.; Peddibhotla, S.; Dahl, R.; Su, Y.; Cosford, N. D.; Roth, G. P.; Pasquale, E. B. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors J. Biol. Chem. 2008, 283, 29461-29472
25. Petty, A.; Myshkin, E.; Qin, H.; Guo, H.; Miao, H.; Tochtrop, G. P.; Hsieh, J. T.; Page, P.; Liu, L.; Lindner, D. J.; Acharya, C.; Mackerell, A. D., Jr.; Ficker, E.; Song, J.; Wang, B. A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis in Vivo PLoS One 2012, 7, e42120
26. Tognolini, M.; Giorgio, C.; Hassan Mohamed, I.; Barocelli, E.; Calani, L.; Reynaud, E.; Dangles, O.; Borges, G.; Crozier, A.; Brighenti, F.; Del Rio, D. Perturbation of the EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites J. Agric. Food Chem. 2012, 60, 8877-8884
27. Noberini, R.; Koolpe, M.; Lamberto, I.; Pasquale, E. B. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols Pharmacol. Res. 2012, 66, 363-373
28. Mohamed, I. H.; Giorgio, C.; Bruni, R.; Flammini, L.; Barocelli, E.; Rossi, D.; Domenichini, G.; Poli, F.; Tognolini, M. Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system Pharmacol. Res. 2011, 64, 464-470
29. Pfeffer, F. M.; Russell, R. A. Strategies and methods for the attachment of amino acids and peptides to chiral [n]polynorbornane templates Org. Biomol. Chem. 2003, 1, 1845-1851
30. Chang, K. H.; Lee, L.; Chen, J.; Li, W. S. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors Chem. Commun. 2006, 629-631
31. Wu, J.; Li, C.; Zhao, M.; Wang, W.; Wang, Y.; Peng, S. A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis Bioorg. Med. Chem. 2010, 18, 6220-6229
32. Himanen, J. P. Ectodomain structures of Eph receptors Semin. Cell. Dev. Biol. 2012, 23, 35-42
33. Molecular Operating Environment (MOE), MOE 2008.10; CCG Inc.: 1255 University Street, Montreal, Quebec, Canada, 2008.
34. Himanen, J. P.; Goldgur, Y.; Miao, H.; Myshkin, E.; Guo, H.; Buck, M.; Nguyen, M.; Rajashankar, K. R.; Wang, B.; Nikolov, D. B. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex EMBO Rep. 2009, 10, 722-728
35. Glide 5.5; Schrodinger LLC: New York, 2009.
36. Lyne, P. D.; Lamb, M. L.; Saeh, J. C. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring J. Med. Chem. 2006, 49, 4805-4808
37. Prime 3.0; Schrodinger LLC: New York, 2009.
38. Rastelli, G.; Del Rio, A.; Degliesposti, G.; Sgobba, M. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA J. Comput. Chem. 2010, 31, 797-810
39. Impact 5.8; Schrodinger LLC: New York, 2009.
40. Guimaraes, C. R.; Cardozo, M. MM-GB/SA rescoring of docking poses in structure-based lead optimization J. Chem. Inf. Model. 2008, 48, 958-970
41. Lema Tome, C. M.; Palma, E.; Ferluga, S.; Lowther, W. T.; Hantgan, R.; Wykosky, J.; Debinski, W. Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor J. Biol. Chem. 2012, 287, 14012-14022
42. Koolpe, M.; Dail, M.; Pasquale, E. B. An ephrin mimetic peptide that selectively targets the EphA2 receptor J. Biol. Chem. 2002, 277, 46974-94697
43. Noberini, R.; Rubio de la Torre, E.; Pasquale, E. B. Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach Cell. Adhes. Migr. 2012, 6, 102-112
44. Miao, H.; Burnett, E.; Kinch, M.; Simon, E.; Wang, B. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation Nature Cell Biol. 2000, 2, 62-69
45. Baell, J. B.; Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 2010, 53, 2719-2740
46. Pellicciari, R.; Gioiello, A.; Macchiarulo, A.; Thomas, C.; Rosatelli, E.; Natalini, B.; Sardella, R.; Pruzanski, M.; Roda, A.; Pastorini, E.; Schoonjans, K.; Auwerx, J. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity J. Med. Chem. 2009, 52, 7958-7961
47. Pellicciari, R.; Costantino, G.; Camaioni, E.; Sadeghpour, B. M.; Entrena, A.; Willson, T. M.; Fiorucci, S.; Clerici, C.; Gioiello, A. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid J. Med. Chem. 2004, 47, 4559-4569
48. Maestro 9.0; Schrodinger LLC: New York, 2009.
49. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids J. Am. Chem. Soc. 1996, 118, 11225-11236
50. Bolt, M. J. Separation of methylated free bile acids from their taurine and methyl glycine conjugates by thin-layer chromatography J. Lipid Res. 1987, 28, 1013-1015
51. Jacobson, A. R.; Gabler, D. G.; Oleksyszyn, J. Bile acid inhibitors of metalloproteinase enzymes. U.S. Patent US005646316A, 1997.